← Back to Clinical Trials
Recruiting NCT07223099

NCT07223099 Sauna for Offline Connections and Interactive, Authentic Living

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07223099
Status Recruiting
Phase —
Sponsor University of California, San Francisco
Condition Loneliness
Study Type INTERVENTIONAL
Enrollment 15 participants
Start Date 2026-04-20
Primary Completion 2027-03-30

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
Sauna Visits

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 15 participants in total. It began in 2026-04-20 with a primary completion date of 2027-03-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This pilot trial will test an intervention (sauna visits) targeting reductions in loneliness in adults aged 19-25 years. Participants will: * Visit a sauna in San Francisco once per week for 2 hours by themselves or with a friend, for 8 weeks total * Complete online surveys throughout their participation The main question this pilot trial aims to answer are: * To what extent do participants find the study design acceptable? * To what extent do participants complete the weekly sauna visits? * To what extent do participants complete the weekly online surveys?

Eligibility Criteria

Inclusion Criteria: * Aged 19-25 * English-speaking * Able to provide written informed consent * Graduated from high school or high school equivalent * Elevated level of loneliness * Able and willing to receive study text messages * Able to attend weekly in-person sauna visits in San Francisco, CA Exclusion Criteria: * Self-reported heat intolerance * Pregnancy, active lactation, or intention to become pregnant during the study period * Regular use of any nicotine products, including cigarettes, vapes, chewing tobacco, or other forms of nicotine (if use is not regular, must be willing to refrain for 24 hours before and 24 hours after sauna visits) * Current social heat practices 2 or more times per month (e.g., visiting sauna or hot tub facilities with others present) * Unwilling to refrain from using marijuana products and alcohol for the 24 hours before and 24 hours after sauna visits * Unwilling to refrain from heavy exercise on the day of sauna visits * Any medical condition that, in the opinion of investigators, may increase the risk of sauna use or introduce excessive variance into physiological or behavioral responses to sauna visits * Use of any medication that might impact thermoregulatory capacity or that, in the opinion of investigators, would increase risk of study participation or introduce excessive variance into physiological or behavioral responses to sauna visits

Contact & Investigator

Central Contact

SOCIAL Study Team

✉ socialstudy@ucsf.edu

📞 415-514-8445

Principal Investigator

Ashley E Mason, PhD

PRINCIPAL INVESTIGATOR

University of California, San Francisco

Frequently Asked Questions

Who can join the NCT07223099 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, up to 25 Years, studying Loneliness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07223099 currently recruiting?

Yes, NCT07223099 is actively recruiting participants. Contact the research team at socialstudy@ucsf.edu for enrollment information.

Where is the NCT07223099 trial being conducted?

This trial is being conducted at San Francisco, United States.

Who is sponsoring the NCT07223099 clinical trial?

NCT07223099 is sponsored by University of California, San Francisco. The principal investigator is Ashley E Mason, PhD at University of California, San Francisco. The trial plans to enroll 15 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology